Home What is Buprenorphine? DATA Physician Locator DATA 2000 FAQs Publications/Reports Links En Español
Physician Waiver Qualifications Waiver Notification Form Upcoming Trainings Waived Physician WebBoard Update Physician Contact Information Model State Medical Board Policy
The Drug Addiction Treatment Act of 2000 (DATA 2000)The Drug Addiction Treatment Act of 2000 (DATA 2000) expands the clinical context of medication-assisted opioid addiction treatment by allowing qualified physicians to dispense or prescribe specifically approved Schedule III, IV, and V narcotic medications for the treatment of opioid addiction in treatment settings other than the traditional Opioid Treatment Program (i.e., methadone clinic). In addition, DATA 2000 reduces the regulatory burden on physicians who choose to practice opioid addiction therapy by permitting qualified physicians to apply for and receive waivers of the special registration requirements defined in the Controlled Substances Act. more
SAMHSA and NIDA Convene Summit on Buprenorphine Treatment
The Summit convened February 21-22, 2008, in Washington, D.C. to bring together experts in epidemiology, pharmacology, toxicology, and addiction treatment in order to build upon the findings of the previous summits in 2003 and 2005. Participants assessed the successes, progress and continued barriers to access to opioid treatment with buprenorphine. Presentations identified best practices and useful clinical supports to enhance the quality of treatment. Participants identified strategies to address emerging issues and concerns. SAMHSA and NIDA will prepare a report on the proceedings.Use this HTML link to view presentations.
Update Physician Contact InformationPhysicians, you can now update your own contact information. If you have given permission to post contact information in the Buprenorphine Physician and Treatment Program Locator, the information will be updated there too. Use this link to go to the update form.
What's New Help with RSS
Treatment Improvement Prototol
Increase Patient Limits
2007 SAMHSA Evaluation of the Impact of the DATA Waiver Program
2006 Report On Diversion and Abuse of Buprenorphine
Drug Enforcement Administraton (DEA)
DATA Physician Locator
CSAT Director Informs Physicians of Increase in Patient Limits
CSAT Director Notifies Physicians of a New Feature to the SAMHSA Buprenorphine Physician and Treatment Program Locator
CSAT Director Advises Physicians of Concerns Regarding Buprenorphine
CSAT Director Encouraging Physicians to Sign-Up for the Buprenorphine Physician and Treatment Program Locator
Follow this RealMedia link to view a Public Service Announcement (PSA) on office-based opioid addiction treatment featuring former Surgeon General Dr. C. Everett Koop.
[Realplayer file, need Realplayer to review] If you do not have RealPlayer, you may download a free copy from Real Networks.
Home | Accessibility | Privacy | Disclaimer | SAMHSA
Department of Health & Human Services | USA.gov
* Adobe™ PDF formatted files require the Adobe™ Reader to properly read them. Use this link to download this FREE program.